2-Year Results of the AUTAX (Austrian Multivessel TAXUS-Stent) RegistryBeyond the SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) Study
Mariann Gyöngyösi, MD, PhD*,*,
Günter Christ, MD*,
Irene Lang, MD*,
Gerhard Kreiner, MD*,
Heinz Sochor, MD*,
Peter Probst, MD*,
Thomas Neunteufl, MD*,
Rosa Badr-Eslam, MD*,
Susanne Winkler, MD*,
Noemi Nyolczas, MD*,
Aniko Posa, PhD*,
Franz Leisch, MD ,
Ronald Karnik, MD ,
Peter Siostrzonek, MD ,
Stefan Harb, MD||,
Matthias Heigert, MD¶,
Gerald Zenker, MD#,
Werner Benzer, MD**,
Gerhard Bonner, MD,
Alexandra Kaider, MSc,
Dietmar Glogar, MD* on behalf of the AUTAX Investigators
* Department of Cardiology, Medical University of Vienna, Vienna, Austria
Allgemeines Krankenhaus der Stadt Linz, Linz, Austria
Rudolfstiftung Vienna, Vienna, Austria
Krankenhaus Barmherzigen Schwestern, Linz, Austria
|| Landeskrankenhaus Graz-West, Graz, Austria
¶ St. Johannes Spital, Salzburg, Austria
# Landeskrankenhaus, Bruck an der Mur, Austria
** Department of Interventional Cardiology, Academic Hospital, Feldkirch, Austria
Confraternität Privatklinik Josefstadt, Vienna, Austria
Core Unit for Medical Statistics and Informatics, Section of Clinical Biometrics, Medical University of Vienna, Vienna, Austria
View larger version (19K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Lesion Localization
Localization of the lesions treated with TAXUS stents in multivessel coronary artery disease. LAD = left anterior descending coronary artery; LCx = left circumflex artery; LM = left main artery; RCA = right coronary artery.
|
|
View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Predictors of MACCE
Hazard ratio with 95% confidence intervals (CIs) up to 2-year major adverse cardiac and cerebrovascular events (MACCE) (Cox proportional hazard model). CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; revasc. = revascularization; UA/NSTEMI = unstable angina/non–ST-segment myocardial infarction.
|
|
View larger version (25K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 Cumulative MACCE-Free Survival in Patients With/Without UA/NSTEMI and Age >70 yrs
(A) MACCE-free survival in UA/NSTEMI. Two-year survival Kaplan-Meier estimates of MACCE-free survival in patients with UA/NSTEMI or stable angina (SA). (B) MACCE-free survival age >70 years. Two-year survival Kaplan-Meier estimates of MACCE-free survival in patients age  70 years. Probability values are calculated with log-rank tests at the time points of clinical controls. Abbreviations as in Figure 2.
|
|
View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4 Cumulative MACCE-Free Survival in Patients With/Without DM and Previous PCI
(A) MACCE-free survival in diabetes mellitus (DM). Two-year survival Kaplan-Meier estimates of MACCE-free survival in patients with or without DM. (B) MACCE-free survival in post-PCI patients. Two-year survival Kaplan-Meier estimates of MACCE-free survival in patients with PCI. Probability values are calculated with log-rank tests at the time points of clinical controls. Abbreviations as in Figure 2.
|
|
View larger version (25K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 5 Cumulative AMI and/or Death-Free Survival in Patients With/Without UA/NSTEMI and Incomplete Revascularization
(A) Death or acute myocardial infarction (AMI)-free survival in UA/NSTEMI. Two-year survival Kaplan-Meier estimates of death or AMI-free survival in patients with UA/NSTEMI or SA. (B) Death or AMI-free survival in complete revascularization (R). Two-year survival Kaplan-Meier estimates of death or AMI-free survival in complete R versus incomplete R. Probability values are calculated with log-rank tests at the time points of clinical controls. Abbreviations as in Figures 2 and 3.
|
|
|
